Napp Pharmaceuticals Limited has been shortlisted for the Chartered Institute of Marketing Excellence Awards for the launch campaign of our most recent oncology product. We are one of four organisations shortlisted in the pharmaceutical/health service provider/medical supplier category.
The Awards recognise marketing excellence across the public and private sectors, and the judges are looking for campaigns that are innovative and creative, and show consideration of the market, challenges and changing customer needs, as well as demonstrating a return on investment. Alison O’Toole, Director of Oncology said, “Benefitting patients is one of our key company aims, so it’s important to us that we communicate effectively to our customers about our new products to ensure that appropriate patients can benefit from them. We also need to make sure that our marketing plans are cost-effective to ensure our sustainaility and our ability to invest in future projects. We were curious to know how our plans compared with others, so entering the Awards was a chance to compare our launch strategy and tactics with the very best in the industry sector and we’re delighted to have been shorlisted.”
The winners of the Awards will be announced at an evening celebration in London in February.